Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Related party disclosures (Tables)

3 Months Ended

Mar. 31, 2016

Transactions entered into in the three months to March 31, 2016 and 2015 are as follows (in thousands):

	For the three months ended March 31,
	2016		2015
Invoiced to Immunocore for reimbursements	$	7	$	2
Purchases from Immunocore	787		1,149

Trading balances outstanding as of March 31, 2016 and December 31, 2015 are as follows (in thousands):

	March 31, 2016		December 31, 2015
Amounts owed from Immunocore	$	1	$	2
Amounts owed to Immunocore	229		288